January 2011:Two corrections have been made to the full version of this guideline as well as to the NICE version and the Quick Reference Guide.
In the section Management of pregnancy with chronic hypertension 'and' has been changed to 'or' in the following recommendation (recommendation 220.127.116.11 in the NICE version). It now reads:
Tell women who take angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs):
that there is an increased risk of congenital abnormalities if these drugs are taken during pregnancy
to discuss other antihypertensive treatment with the healthcare professional responsible for managing their hypertension, if they are planning pregnancy.
In addition, 'chlorothiazide diuretics' has been changed to 'chlorothiazide' in recommendations 18.104.22.168 and 22.214.171.124 in the NICE guideline and throughout the full guideline. These changes have been made on pages 4 and 8 of the Quick Reference Guide. Implementation tools have also been updated.
This web version of the NICE guideline incorporates these changes.